Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Arch Virol ; 157(3): 467-74, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22198411

RESUMO

The genetic diversity of the hypervariable region I of S1 gene (HVR I) of infectious bronchitis (IB) vaccine strains H120, Ma5 and 4/91 was compared to that of 26 infectious bronchitis virus (IBV) strains isolated from the field in Guangxi province of China during the years 1985-2008, and the field isolates were classified into five major genotypes. Monovalent antisera against three vaccine strains and seven field isolates of different genotypes were prepared by immunizing rabbits with mineral oil adjuvant preparations containing viruses propagated in chicken embryos. Virus neutralization (VN) tests were performed in tracheal organ cultures (TOCs) using these 10 strains with the antisera, and a one-way VN test was then used to compare the relationship of 10 monovalent antisera to the other 19 field isolates. As a result, seven different serotypes were classified based on the results of VN tests with the 26 isolates plus the three vaccine strains. We found that different serotypes were prevalent during different time periods, that more new serotypes have been prevalent in more recent years, and the prevalence of the original dominant serotype has been in constant decline since 2004. In addition, the concordance rate of the 26 field isolates between the S1 genotypes and serotypes was 57.7%.


Assuntos
Infecções por Coronavirus/veterinária , Variação Genética , Vírus da Bronquite Infecciosa/classificação , Vírus da Bronquite Infecciosa/isolamento & purificação , Doenças das Aves Domésticas/epidemiologia , Doenças das Aves Domésticas/virologia , Animais , Anticorpos Antivirais , Embrião de Galinha , Galinhas , China , Análise por Conglomerados , Infecções por Coronavirus/epidemiologia , Infecções por Coronavirus/virologia , Genótipo , Vírus da Bronquite Infecciosa/genética , Vírus da Bronquite Infecciosa/imunologia , Dados de Sequência Molecular , Testes de Neutralização , Filogenia , Prevalência , RNA Viral/genética , Coelhos , Análise de Sequência de DNA , Sorotipagem
2.
Vet Microbiol ; 106(1-2): 129-37, 2005 Mar 20.
Artigo em Inglês | MEDLINE | ID: mdl-15737482

RESUMO

The ability of the avian pathogen Mycoplasma gallisepticum to persist despite fluoroquinolone treatment was investigated in chickens. Groups of specific pathogen free chickens were experimentally infected with M. gallisepticum and treated with enrofloxacin at increasing concentrations up to the therapeutic dose. When M. gallisepticum could no longer be re-isolated from chickens, birds were stressed by inoculation of infectious bronchitis virus or avian pneumovirus. Although M. gallisepticum could not be cultured from tracheal swabs collected on several consecutive sampling days after the end of the enrofloxacin treatments, the infection was not eradicated. Viral infections reactivated the mycoplasma infection. Mycoplasmas were isolated from tracheal rings cultured for several days, suggesting that M. gallisepticum persisted in the trachea despite the enrofloxacin treatment. The minimal inhibitory concentration (MIC) of enrofloxacin for most of the re-isolated mycoplasmas was the same as that of the strain with which the birds were inoculated. Furthermore, no mutation could be detected in the fluoroquinolone target genes. These results suggest that M. gallisepticum can persist in chickens without development of resistance despite several treatments with enrofloxacin.


Assuntos
Antibacterianos/uso terapêutico , Galinhas , Fluoroquinolonas/uso terapêutico , Infecções por Mycoplasma/veterinária , Mycoplasma gallisepticum/crescimento & desenvolvimento , Doenças das Aves Domésticas/tratamento farmacológico , Doenças das Aves Domésticas/microbiologia , Quinolonas/uso terapêutico , Animais , Antibacterianos/sangue , DNA Bacteriano/química , DNA Bacteriano/genética , Enrofloxacina , Fluoroquinolonas/sangue , Vírus da Bronquite Infecciosa/isolamento & purificação , Metapneumovirus/isolamento & purificação , Testes de Sensibilidade Microbiana/veterinária , Infecções por Mycoplasma/sangue , Infecções por Mycoplasma/tratamento farmacológico , Infecções por Mycoplasma/microbiologia , Mycoplasma gallisepticum/genética , Reação em Cadeia da Polimerase/veterinária , Doenças das Aves Domésticas/sangue , Quinolonas/sangue , Distribuição Aleatória , Doenças Respiratórias/sangue , Doenças Respiratórias/tratamento farmacológico , Doenças Respiratórias/microbiologia , Doenças Respiratórias/veterinária , Organismos Livres de Patógenos Específicos , Traqueia/microbiologia
3.
Arch Virol ; 49(2-3): 207-16, 1975.
Artigo em Inglês | MEDLINE | ID: mdl-174524

RESUMO

Avian infectious bronchitis virus grown in ovo was purified by differential centrifugation and isopycnic sedimentation in density gradients. The purified virus was analysed by SDS polyacrylamide gel electrophoresis and found to comprise up to sixteen polypeptides, four of which were glycopeptides. Bromelain treatment of the particles removed three polypeptides and two glycopeptides.


Assuntos
Coronaviridae/análise , Vírus da Bronquite Infecciosa/análise , Peptídeos/análise , Proteínas Virais/análise , Bromelaínas , Técnicas de Cultura , Glicopeptídeos/análise , Vírus da Bronquite Infecciosa/crescimento & desenvolvimento , Vírus da Bronquite Infecciosa/isolamento & purificação , Peso Molecular , RNA Viral/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA